New Chemically-activated Antigen Could Expedite Development Of HIV Vaccine
Tuesday, September 29, 2009 - 19:28
in Biology & Nature
Scientists working to develop a vaccine for the human immunodeficiency virus report they have created the first antigen that induces protective antibodies capable of blocking infection of human cells by genetically-diverse strains of HIV. The new antigen differs from previously-tested vaccines by virtue of its chemically-activated property that enables close sharing of electrons and produces strong covalent bonding. Researchers used a mouse model to generate the antibodies.
Read the whole article on Science Daily
More from Science Daily
Related
- New chemically-activated antigen could expedite development of HIV vaccineMon, 21 Sep 2009, 14:37:33 EDT
- NIAID media availability: New strategy proposed for designing antibody-based HIV vaccineSun, 14 Jun 2009, 14:35:45 EDT
- New intranasal influenza vaccine triggers robust immunity with significantly less antigenTue, 28 Oct 2008, 14:35:32 EDT
- Novel vaccine approach offers hope in fight against HIVSun, 17 May 2009, 13:30:19 EDT
- Method for fast human antibodies against flu could find broad useWed, 30 Apr 2008, 17:00:25 EDT